Callahan Advisors LLC Has $9.33 Million Holdings in Corteva, Inc. $CTVA

Callahan Advisors LLC lessened its holdings in shares of Corteva, Inc. (NYSE:CTVA) by 6.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 139,237 shares of the company’s stock after selling 10,302 shares during the quarter. Callahan Advisors LLC’s holdings in Corteva were worth $9,333,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of CTVA. Brighton Jones LLC increased its position in Corteva by 307.2% during the fourth quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock worth $888,000 after buying an additional 11,760 shares during the last quarter. Woodline Partners LP grew its position in shares of Corteva by 40.3% in the first quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock valued at $3,645,000 after purchasing an additional 16,644 shares during the last quarter. EverSource Wealth Advisors LLC grew its position in shares of Corteva by 62.1% in the second quarter. EverSource Wealth Advisors LLC now owns 2,559 shares of the company’s stock valued at $191,000 after purchasing an additional 980 shares during the last quarter. Cresset Asset Management LLC grew its position in shares of Corteva by 2.6% in the second quarter. Cresset Asset Management LLC now owns 7,063 shares of the company’s stock valued at $526,000 after purchasing an additional 181 shares during the last quarter. Finally, Jump Financial LLC acquired a new position in shares of Corteva in the second quarter valued at approximately $1,464,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Insider Activity at Corteva

In other news, insider Brian Titus sold 8,311 shares of the stock in a transaction on Friday, February 20th. The stock was sold at an average price of $76.55, for a total value of $636,207.05. Following the completion of the transaction, the insider directly owned 8,090 shares in the company, valued at approximately $619,289.50. This represents a 50.67% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.15% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have recently commented on CTVA. Weiss Ratings raised Corteva from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, May 7th. Deutsche Bank Aktiengesellschaft upped their target price on Corteva from $90.00 to $100.00 in a research report on Monday, May 11th. CICC Research upped their target price on Corteva from $80.00 to $93.00 and gave the company an “outperform” rating in a research report on Wednesday, May 13th. Argus upped their target price on Corteva from $80.00 to $91.00 and gave the company a “buy” rating in a research report on Tuesday, March 31st. Finally, Wolfe Research upped their target price on Corteva from $81.00 to $86.00 and gave the company an “outperform” rating in a research report on Thursday, February 5th. Thirteen investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat, Corteva presently has a consensus rating of “Moderate Buy” and a consensus target price of $88.14.

Corteva Stock Down 0.3%

NYSE CTVA opened at $78.77 on Thursday. The business has a fifty day moving average price of $81.25 and a two-hundred day moving average price of $73.79. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.47 and a quick ratio of 1.03. Corteva, Inc. has a fifty-two week low of $60.53 and a fifty-two week high of $85.63. The stock has a market capitalization of $52.68 billion, a PE ratio of 46.33, a PEG ratio of 2.42 and a beta of 0.59.

Corteva (NYSE:CTVA) last released its earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share for the quarter, topping the consensus estimate of $1.18 by $0.32. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The firm had revenue of $4.91 billion during the quarter, compared to analysts’ expectations of $4.64 billion. During the same period in the prior year, the company earned $1.13 earnings per share. The company’s quarterly revenue was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities analysts expect that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, June 15th. Stockholders of record on Monday, June 1st will be paid a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Monday, June 1st. Corteva’s dividend payout ratio is presently 42.35%.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.